Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FibroGen to Present at Goldman Sachs 45th Annual Global Healthcare Conference
-
Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
-
At ASCO 2024, Treos Bio Reports Key Survival Results for Chemo-Free Regimen of PolyPEPI1018 Peptide Immunotherapy and Roche’s PD-L1 Inhibitor in Late-Stage Colorectal Cancer
-
ATHA Energy Commences 2024 Angilak Diamond Drilling Exploration Program
-
Osisko Development to Complete Second Deferred Payment Installment in Connection With the Tintic Acquisition
-
Skye Bioscience to Present at Jefferies Global Healthcare Conference
-
Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)
-
Lithium Drilling Program Commences at East Vallée
-
Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors
-
Smart Share Global Limited Announces First Quarter 2024 Results
-
PawFury's Presale Raises Over $3 Million, Set To Surpass Pepe and SHIB
-
NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with COVIRIX
-
ATHA Energy Commences 2024 Angilak Diamond Drilling Exploration Program
-
District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch
-
Talisker Provides Update on the Second Draw on the US$31,250,000 Financing with Sprott Streaming and Royalty for the Bralorne Gold Project
-
Flash News: OKX Launches Exclusive Aptos Airdrop Campaign Featuring 1,000 APT Prize Pool
-
Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
-
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting
-
Osisko Development to Complete Second Deferred Payment Installment in Connection With the Tintic Acquisition
-
Canoo Announces Participation in June Investor Conferences
-
Colliers to Acquire Leading Canadian Engineering Firm Englobe
-
ETFS Capital Delivers for WisdomTree Stockholders
-
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
-
Whitestone REIT Continues Board Refreshment
-
Introba Appoints Gary Hamilton as Senior Vice President – Growth Leader, Americas
-
iBio Closes Sale of Manufacturing Facility in Texas
-
Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference
-
University of Rochester’s Eastman School of Music Recognized in the QS World University Rankings
-
Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation
-
Alpine Income Property Trust Announces Sale of a Senior Portion of First Mortgage Loan Investment
-
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
-
Invesco Ltd: Form 8.3 - Virgin Money UK PLC Public dealing disclosure
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
Transactions in connection with share buyback programme
-
Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia
-
Form 8.3 - Darktrace Plc
-
Changes in the number of own shares held by Aktia Bank Plc
-
Form 8.3 - Hargreaves Lansdown Plc
-
Prepayments, Realkredit Danmark A/S
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
DirectRx Pharmacy Announces Changes to Executive Leadership Team
-
Worthington Enterprises Completes Acquisition of Hexagon Ragasco
-
Invesco Ltd: Form 8.3 - DS Smith PLC
-
IN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Society of Clinical Oncology Annual Meeting
-
Fanhua Announces Strategic Partnership with Baidu AI Cloud for Application of Large Model in Insurance Distribution
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Presto Pilots Drive-Thru Voice AI at Taco John’s
-
MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Patients at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024
